Morgan Stanley’s Acurx Pharmaceuticals ACXP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.2K | Hold |
106,201
| – | – | ﹤0.01% | 6331 |
|
|
2025
Q1 | $41.4K | Hold |
106,201
| – | – | ﹤0.01% | 6333 |
|
|
2024
Q4 | $86.4K | Buy |
106,201
+60,000
| +130% | +$48.8K | ﹤0.01% | 6111 |
|
|
2024
Q3 | $87.8K | Sell |
46,201
-200
| -0.4% | -$380 | ﹤0.01% | 6054 |
|
|
2024
Q2 | $104K | Buy |
46,401
+20,000
| +76% | +$45K | ﹤0.01% | 5942 |
|
|
2024
Q1 | $64.7K | Sell |
26,401
-6,001
| -19% | -$14.7K | ﹤0.01% | 6128 |
|
|
2023
Q4 | $124K | Buy |
32,402
+17,402
| +116% | +$66.7K | ﹤0.01% | 6093 |
|
|
2023
Q3 | $22.5K | Buy |
+15,000
| New | +$22.5K | ﹤0.01% | 6443 |
|
|
2022
Q1 | – | Sell |
-3
| Closed | – | – | 7939 |
|
|
2021
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 7954 |
|